PALMISANO ROBERT J - 19 Mar 2024 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role: Director, 10%+ Owner
Signature: /s/ Alexander Wilson as attorney-in-fact for Robert J. Palmisano
Issuer symbol: AEON
Transactions as of: 19 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 21 Mar 2024, 19:51:04 UTC
Previous filing: 16 Aug 2023
Next filing: 10 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AEON	Stock Option	Award	$0	+16,260		$0.000000	16,260	19 Mar 2024	Common Stock	16,260	$14.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. Each option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company.

Content

Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. Each option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company.